GBS Inc. (GBS): Price and Financial Metrics Recent IPO


GBS Inc. (GBS): $4.45

0.13 (+3.01%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

GBS Stock Price Chart Interactive Chart >

Price chart for GBS

GBS Price/Volume Stats

Current price $4.45 52-week high $14.24
Prev. close $4.32 52-week low $2.44
Day low $4.33 Volume 455,200
Day high $4.75 Avg. volume 492,491
50-day MA $3.83 Dividend yield N/A
200-day MA $0.00 Market Cap 55.10M

GBS Inc. (GBS) Company Bio


GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It operates in Mainland China, Hong Kong, Vietnam, and Bangladesh. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was founded in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.


GBS Latest News Stream


Event/Time News Detail
Loading, please wait...

GBS Latest Social Stream


Loading social stream, please wait...

View Full GBS Social Stream

Latest GBS News From Around the Web

Below are the latest news stories about GBS Inc that investors may wish to consider to help them evaluate GBS as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're at the midpoint of the week now and we're still going strong with a look at the biggest pre-market stock movers for Wednesday.

William White on InvestorPlace | June 16, 2021

We Think GBS (NASDAQ:GBS) Needs To Drive Business Growth Carefully

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Yahoo | June 15, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Good morning, investors!

William White on InvestorPlace | June 11, 2021

Patients Living With Diabetes Voice Eagerness for ‘Finger-Prick’ Alternative in Global Glucose Monitoring Survey

Global results show 90% of patients are in favor of a saliva-based glucose testNEW YORK, June 08, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced survey results from more than 300 patients globally as part of its development and go-to-market strategy. As GBS is advancing to clinical trials of its saliva glucose biosensor, it conducte

Yahoo | June 8, 2021

Will GBS (NASDAQ:GBS) Spend Its Cash Wisely?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Yahoo | June 8, 2021

Read More 'GBS' Stories Here

GBS Price Returns

1-mo 42.17%
3-mo -32.16%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD -39.86%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5955 seconds.